Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-, 4-oxide, (11bS)-
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-, 4-oxide, (11bS)- Basic information
- Product Name:
- Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-, 4-oxide, (11bS)-
- Synonyms:
-
- Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-, 4-oxide, (11bS)-
- (S)-3,3'-Bis(9-anthracenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-bi-2-naphthyl Hydrogen Phosphate
- CAS:
- 2099033-14-2
- MF:
- C48H37O4P
- MW:
- 708.78
- Mol File:
- 2099033-14-2.mol
More
Less
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-, 4-oxide, (11bS)- Chemical Properties
- Density
- 1.40±0.1 g/cm3(Predicted)
- pka
- 1.17±0.20(Predicted)
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-, 4-oxide, (11bS)-Supplier
Daicel Chiral Technologies (China)CO.,LTD
- Tel
- 021-50460086-9 15921403865
- han_yajun@dctc.daicel.com
Tianjin Derchemist Science & Technology Co., Ltd.
- Tel
- 22-58627059 13920586291
- zdcomcon@126.com
Bide Pharmatech Ltd.
- Tel
- 400-1647117 15221909166
- product02@bidepharm.com
Shanghai Anyinuo Biomedical Technology Co., Ltd.
- Tel
- 021-34625901
- 420970979@qq.com
Shanghai Suifu Chemical Technology CO.,LTD.
- Tel
- +86-021-33738187 +86-17736114707
- suifuchemical@163.com
More
Less
Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 2,6-di-9-anthracenyl-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-, 4-oxide, (11bS)-(2099033-14-2)Related Product Information
- R-3,3'-bis(4-nitrophenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin, 8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-bis(4-methoxyphenyl)-, 4-oxide, (11bS)-
- (11bS)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- (R)-4-oxide-2,6-bis[4-(1,1-dimethylethyl)phenyl]-8,9,10,11,12,13,14,15-octahydro-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- R-3,3'-bis(2-Naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- (S)-3,3'-Bis[3,5-bis(trifluoromethyl)phenyl]-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl Hydrogen Phosphate
- (11bR)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-bis([1,1':3',1''-terphenyl]-5'-yl)-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin,99%e.e.
- (S)-4-oxide-2,6-bisbis([1,1':3',1''-terphenyl]-5'-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxydinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- R-4-oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-diphenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- R-3,3'-bis(3,5-diMethylphenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- (S)-5,5',6,6',7,7',8,8'-Octahydro-1,1'-bi-2-naphthyl phosphate
- (11bR)-2,6-Bis([1,1'-biphenyl]-4-yl)-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- (S)-3,3'-Bis(2-naphthyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl Hydrogen Phosphate
- (11bS)-8,9,10,11,12,13,14,15-Octahydro-4-hydroxy-2,6-diphenyl-4-oxide-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- R-4-oxide-8,9,10,11,12,13,14,15-octahydro-4-hydroxy-2,6-di-9-phenanthrenyl-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- S- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin
- R-3,3'-bis((3,5-bis(trifluoroMethyl)phenyl)-5,5',6,6',7,7',8,8'-octahydro-1,1'-binaphthyl-2,2'-diyl hydrogenphosphate
- R- 4-oxide-2,6-bis([1,1'-biphenyl]-4-yl)-4-hydroxy-Dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepin